Search results
Showing 1 to 15 of 18 results for extracorporeal membrane oxygenation
Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adults
Awaiting development [GID-IPG10411] Expected publication date: 06 August 2025
Extracorporeal membrane oxygenation (ECMO) in postneonatal children (IPG38)
Evidence-based recommendations on extracorporeal membrane oxygenation in postneonatal children. This involves connecting the child's internal circulation to an external blood pump and artificial lung.
View recommendations for IPG38Show all sections
Sections for IPG38
Extracorporeal membrane oxygenation for severe acute respiratory failure in adults (IPG391)
Evidence-based recommendations on extracorporeal membrane oxygenation for severe acute respiratory failure in adults. This involves using a tube to carry blood from the right side of the heart and then pump it through an artificial lung where it picks up oxygen.
View recommendations for IPG391Show all sections
Sections for IPG391
Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)
Evidence-based recommendations on extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults. This involves using an artificial lung to oxygenate the blood outside the body.
Question NICE encourages further research into efficacy of extracorporeal membrane oxygenation (ECMO) for acute heart failure. This...
Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)
NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19 .
NICE has developed a medtech innovation briefing (MIB) on CentriMag for heart failure .
Evidence-based recommendations on ex-situ machine perfusion for extracorporeal preservation of lungs for transplant. This involves using a machine to deliver an oxygenated solution to a donor lung and keep it at normal body temperature until it can be transplanted.
View recommendations for IPG695Show all sections
Extracorporeal carbon dioxide removal for acute respiratory failure (IPG776)
Evidence-based recommendations on extracorporeal carbon dioxide removal for acute respiratory failure. This involves taking blood out of the circulatory system and passing it across a synthetic membrane that allows some of the carbon dioxide in the blood to be removed. The blood is then returned to the circulatory system.
View recommendations for IPG776Show all sections
explanatory notes(if applicable) Evidence on the safety of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory...
support (for example, invasive mechanical ventilation or extracorporeal membrane oxygenation [ECMO])• hospitalisation metrics (for...
NICE has developed a medtech innovation briefing (MIB) on CytoSorb therapy for sepsis .
NPi-200 for pupillary light reflex in critical care patients (MIB235)
NICE has developed a medtech innovation briefing (MIB) on NPi-200 for pupillary light reflex in critical care patients .
This guidance has been updated and replaced by NICE interventional procedure guidance 391.
Extra corporeal membrane oxygenation for acute heart failure in children
Discontinued [GID-IP1153]